Pharmachem Gains Phase 2 Claims Agreement, Plus Patent For New Product
This article was originally published in The Tan Sheet
Executive Summary
Pharmachem Laboratories' experience with claims for its Phase 2 starch-neutralizer branded ingredient may provide an example for firms seeking to validate claims with the FDA, the firm says
You may also be interested in...
House Republicans Seek Top Down Change To FDA’s Warning-Letter Appeals
FDA leadership needs to review the agency's enforcement dispute resolution process, according to ranking Republicans on the House Energy and Commerce Committee
House Republicans Seek Top Down Change To FDA’s Warning-Letter Appeals
FDA leadership needs to review the agency's enforcement dispute resolution process, according to ranking Republicans on the House Energy and Commerce Committee
House Republicans Seek Top Down Change To FDA’s Warning-Letter Appeals
FDA leadership needs to review the agency's enforcement dispute resolution process, according to ranking Republicans on the House Energy and Commerce Committee